Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-25-002511
Filing Date
2025-07-03
Accepted
2025-07-03 13:46:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4318
  Complete submission text file 0000929638-25-002511.txt   6039
Mailing Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 150 BETHESDA MD 20814 (877) 843-3831
AdvisorShares Trust (Filed by) CIK: 0001408970 (see all company filings)

EIN.: 260636087 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A

Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Subject) CIK: 0001892500 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93839 | Film No.: 251104911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)